Capsida Biotherapeutics

1300 Rancho Conejo Blvd.
Thousand Oaks
CA
91320
United States

2023 Best Places to Work
NextGen Class of 2022
Show jobs for this employer

About Capsida Biotherapeutics

Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening disorders.

In the past, nearly all gene therapies have been aimed at treating rare disorders in infants – partially because of tremendous unmet need in those patients but mainly because of the limitations of naturally occurring AAV capsids. At Capsida, we’re not limited by the way things have always been done. We’ve developed a high throughput platform to biologically screen and identify proprietary engineered capsids to significantly improve target specificity and penetration in disease tissues and cells, allowing the use of gene therapy in both rare and common diseases across all ages.

Through intravenous (IV) delivery of a single, engineered capsid, Capsida’s technology can target single or multiple organs simultaneously while limiting exposure to non-targeted organs.

11 articles with Capsida Biotherapeutics